Adult Cognitive DiseaseThe research corpus Monographs

APOE4 Hub

A single polymorphism activating 8+ pathogenic mechanisms simultaneously — both loss-of-function AND gain-of-function.

Pathogenic Mechanisms

  • Loss of disulfide bridge = unprotected PUFA cargo = lipid peroxidation
  • Impaired retromer function and endosomal trafficking
  • Reduced excitatory tone
  • Altered lipid raft organization and complement activation
  • Promotes Ephexin5-RhoA activation and dendritic spine collapse
  • Degrades reelin signaling at the shared ApoER2/VLDLR lipoprotein receptors — apoE and reelin compete for the same receptor system, so ApoE4's impaired receptor recycling is predicted to blunt the protective reelin→Dab1 brake on tau

Key Concept

APOE4 is simultaneously loss-of-function AND gain-of-function, making it a uniquely powerful risk factor that feeds into nearly every other convergence node.

To be populated after CSC grading.

See Also

Papers converging on this axis

8
The Licensing Tyrosine 6 concepts · 8 genes shared The synapse that could not switch off 6 concepts · 8 genes shared The Crowded Cleft 6 concepts · 6 genes shared The Return Leg 5 concepts · 8 genes shared The Unthrown Switch 5 concepts · 7 genes shared The Architect's Handshake 5 concepts · 6 genes shared The Architect's Reprieve 5 concepts · 6 genes shared The Architect's Understudy 5 concepts · 6 genes shared

Concepts on this axis

347
Abeta aggregation as necessary initiating eventAbeta as stress response markerAcyloxyacyl Hydrolase NeuroprotectionAD as accelerated aging of Abeta managementAD as accumulation of insults exceeding homeostasisAD as clinical syndrome not diseaseAD caused by APP dysregulation not Abeta per seAdult NeurogenesisAge-dependent feedback loops in neurodegenerationAge-dependent threshold modelAge-related immune dysfunction enables neurotropic virusesAging accelerators and deceleratorsAging as MechanismAging as root cause of ADAging-epigenetic-genetic interactionAI Disease Model DiscoveryAI Neurotherapeutic DiscoveryAI-based early diagnosisAluminum as primary environmental causeAluminum driving amyloid productionAmyloid and tau as secondary byproductsAmyloid as antimicrobial defenseAmyloid as downstream secondaryAmyloid clearance as important as depositionAmyloid Clinical DisconnectAmyloid NucleationAmyloid plaques as fibrotic scar tissue from BBB repairAmyloid-beta as innate immune defenseAnti Ferroptotic BotanicalsAntibody Target SpecificityAntimicrobial DefenseAntimicrobial hypothesis of amyloidAntioxidant defense failureApoE isoform-heparin binding differencesApoE-centric unified modelAPOE4 Endolysosomal DysfunctionAPOE4 Pathogen InteractionApoE4 structural vulnerabilityAPP and tau pathology linked through transport disruptionAPP as dependence receptor

Last reviewed 3 July 2026.

Important noticeThis is a research platform, not a medical site. Nothing here is medical advice, a diagnosis, or a treatment recommendation, and none of it has been reviewed by a regulator. The drugs, doses and trials discussed are research literature, not prescriptions. If dementia affects you or someone you care about, speak to a doctor.

Compiled from the knowledge base and the research corpus under the Organic Network Synthesis methodology · the research corpus of Adult Cognitive Disease · the seven monographs are here. 2026.

827 interlinked articles · 120 papers in full · 53 as typeset PDFs · 635 concepts · 7 convergence nodes · 5 temporal stages.

Discussion

Corrections and disagreements are welcome here, and citation corrections most of all. Posting needs a GitHub account. Please read Taking Part first — in particular, nothing here is medical advice.